Not applicableStudy completedNCT04672772
What this trial is testing
Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.
Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 531